Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026)

Analysis

Dr Reddys Laboratories (RDY) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.95%
Mar 31, 2026 10.12%
Dec 31, 2025 10.97%
Sep 30, 2025 11.23%
Jun 30, 2025 11.01%
Mar 31, 2025 9.34%
Dec 31, 2024 8.83%
Sep 30, 2024 6.86%
Jun 30, 2024 4.41%
Mar 31, 2024 3.84%
Dec 31, 2023 2.41%
Sep 30, 2023 1.08%
Jun 30, 2023 -0.36%
Mar 31, 2023 -2.11%
Dec 31, 2022 1,440.66%
Sep 30, 2022 1,445.77%
Jun 30, 2022 -0.34%
Mar 31, 2022 -14.26%
Dec 31, 2021 1,484.31%
Sep 30, 2021 1,480.20%